Atossa Therapeutics (NASDAQ:ATOS – Free Report) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday. Atossa Therapeutics Trading Down 1.6 % ATOS opened at $1.26 on Thursday. Atossa Therapeutics has a 12-month low of $0.50 and a 12-month […]
Atossa Therapeutics (NASDAQ:ATOS – Get Rating) will be releasing its earnings data on Monday, May 15th. Atossa Therapeutics (NASDAQ:ATOS – Get Rating) last announced its quarterly earnings results on Wednesday, March 22nd. The company reported ($0.06) earnings per share (EPS) for the quarter. Atossa Therapeutics Stock Performance NASDAQ:ATOS opened at $0.70 on Friday. The firm […]
Atossa Therapeutics, Inc. (NASDAQ:ATOS – Get Rating) shares crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.75 and traded as low as $0.72. Atossa Therapeutics shares last traded at $0.74, with a volume of 238,002 shares traded. Wall Street Analysts […]
Atossa Therapeutics (NASDAQ:ATOS – Get Rating) issued its quarterly earnings data on Wednesday. The company reported ($0.06) earnings per share (EPS) for the quarter, Yahoo Finance reports. Atossa Therapeutics Price Performance NASDAQ ATOS traded down $0.02 on Thursday, hitting $0.70. The stock had a trading volume of 109,640 shares, compared to its average volume of […]